Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Empagliflozin 25mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Therapeutic Category
Antidiabetic, ENDOCRINOLOGY and Hormonal range, Endocrinology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹350/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Emplozin SM 25 Tablet is a combination therapy for the treatment of Type 2 diabetes mellitus in adults. It contains three active ingredients: Empagliflozin, Sitagliptin, and Metformin, each targeting different aspects of glucose regulation to help manage blood sugar levels effectively. This tablet is designed for patients who are not adequately controlled on diet, exercise, or other medications alone.
Together, these medications work synergistically to improve glycemic control, both in fasting and postprandial states. Emplozin SM 25 Tablet is recommended for patients with Type 2 diabetes who have not achieved optimal blood glucose levels through diet, exercise, and other oral medications. This combination helps manage blood sugar levels and reduces the risk of complications related to diabetes.
Possible side effects include nausea, headache, abdominal pain, dizziness, and risk of low blood sugar (especially when used with other anti-diabetic medications). Severe effects may include lactic acidosis or kidney problems.
For the treatment of Type 2 diabetes mellitus in adults to improve blood glucose control, alongside diet and exercise.
Not recommended for patients with severe kidney disease or diabetic ketoacidosis. Kidney function should be monitored regularly during treatment.
Store at room temperature, away from moisture and heat. Keep out of reach of children.
Composition : Empagliflozin (10mg) + Linagliptin (5mg)
Composition : Empagliflozin (25mg) + Linagliptin (5mg)
Composition : Empagliflozin (10mg) Tablet
Composition : Empagliflozin (12.5mg) + Metformin (1000mg)
Composition : Empagliflozin (12.5mg) + Metformin (500mg)
Composition : Empagliflozin (5mg) + Metformin (500mg)
Composition : Empagliflozin (10mg) + Sitagliptin 100mg
Composition : Empagliflozin (25mg) + Sitagliptin (100mg) Tablet
Composition : Empagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin (25mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This advanced triple-combination anti-diabetic formulation is widely used in type 2 diabetes management, making it a high-value prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from strong demand in type 2 diabetes, blood sugar control, insulin resistance management, cardiovascular risk reduction support, and long-term glycemic control. The extended-release formulation improves patient compliance and is commonly prescribed by diabetologists and physicians for multi-drug diabetes management.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Empagliflozin 25mg + Sitagliptin 100mg + Metformin 1000mg Extended Release Tablets with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, growing diabetic patient populations, repeat monthly therapy usage, and high acceptance in diabetology and general medicine segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this anti-diabetic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.